SCHEMBL2770296

SCHEMBL2770296

CCCCCNC(=O)N(S)c1noc2c(F)cccc12

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 2/20 0.37
NPY1R P25929 1/20 0.35
RECQL P46063 1/20 0.35
NPY2R P49146 1/20 0.35
EPHX2 P34913 2/20 0.35
NPC1 O15118 2/20 0.35
HTT P42858 2/20 0.35
RAB9A P51151 2/20 0.35
LMNA P02545 1/20 0.35
TP53 P04637 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HIF1A Q16665 1/20 0.35
NAAA Q02083 1/20 0.34
HPGD P15428 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
EPHX1 P07099 3/20 0.33
PLA2G7 Q13093 1/20 0.33
ALDH1A1 P00352 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2769703 0.99 EPHX2 (0.37) SSTR4NPY1RRECQLNPY2REPHX2
SCHEMBL2769902 0.99 EPHX2 (0.37) SSTR4NPY1RRECQLNPY2REPHX2
SCHEMBL2769975 0.99 EPHX2 (0.37) SSTR4NPY1RRECQLNPY2REPHX2
SCHEMBL2770288 0.81 SSTR4 (0.39) SSTR4NPC1RAB9ATP53SMN1; SMN2
SCHEMBL2767451 0.79 ALDH1A1 (0.48) LMNASMN1; SMN2MAPK1ALDH1A1
SCHEMBL4350070 0.73 NAAA (0.40) EPHX2HTTSMN1; SMN2NAAAHPGD
SCHEMBL2770294 0.72 SMN1; SMN2 (0.50) NPC1HTTRAB9ALMNATP53
SCHEMBL2769971 0.71 SMN1; SMN2 (0.49) EPHX2NPC1HTTRAB9ALMNA
SCHEMBL2769700 0.71 SMN1; SMN2 (0.49) EPHX2NPC1HTTRAB9ALMNA
SCHEMBL2769899 0.71 SMN1; SMN2 (0.49) EPHX2NPC1HTTRAB9ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1881967-B1 SUBSTITUTED BENZO(D)ISOXAZOL-3-YL AMINE COMPOUNDS AS ANALGESICS GRUENENTHAL GMBH (DE) 2010-04-28 EP claimed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US claimed
US-7696238-B2 Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics GRUENENTHAL GMBH (DE) 2010-04-13 US disclosed
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics GRUENENTHAL GMBH (DE) 2008-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080176915-A1 Substituted Benzo[d]isoxazol-3-yl Amine Compounds as Analgesics KCNQ1, KCNQ2, KCNQ3 SSTR4 3748/4885NPY1R 379/4885RECQL 723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.